1. Akers, W. A. (1982). Topical corticosteroids: proof of efficacy in skin diseases. In Kligman, A. M. and Leyden, J. J. (Eds.), Safety and Efficacy of Topical Drugs and Cosmetics. Grune and Stratton, New York, pp. 1–23
2. Allen, A. M. (1982). Design methodology in trials of topical drugs. In Kligman, A. M. and Leyden, J. J. (Eds.), Safety and Efficacy of Topical Drugs and Cosmetics. Grune and Stratton, New York, pp. 25–49
3. Barry, B. W. (1983). Dermatological formulations: percutaneous absorption. In Swarbrick, J. (Ed.), Drugs and the Pharmaceutical Sciences, Vol. 18. Marcel Dekker, New York, Basle, pp. 264–95
4. Barry, B. W. and Woodford, R. (1978). Activity and bioavailability of topical steroids. In vivo/in vitro correlations for the vasoconstrictor test. Journal of Clinical Pharmacy, 3, 43–65
5. Bisgaard, H. and Kristensen, J. K. (1984). Quantitation of microcirculatory blood flow changes in human cutaneous tissue induced by inflammatory mediators. Journal of Investigative Dermatology, 83, 184–7